Thanks for joining.   Today we will discuss a new trend call "drug repurposing" or the practice of finding new uses for brand products that have lost their patent protection.Is this a way to lower drug costs or a bad idea going in t...

Today we will review an interesting topic which came across my newsfeed over the weekend.   How are health systems addressing what they refer to as ultra high cost drugs and what are there potential management strategies.The article...

Twenty years after their groundbreaking research, we review Dr. McClellan and Dr. Cutler' research into a very intriguing question pertaining to the value of new innovation.   Even though several years have gone by, the message is still th...

The 340B program was established to offer "covered outpatient" pharmaceutical products at deeply discounted unit prices through purchases made by disproportionate share hospitals [providing care to low income patients] and other "covered entiti...

Understanding the factors that have shaped the evolution of managed care over the past 30 years could offer valuable insights into the future development of health insurance plans and the markets they operate in.   Join me as we examine ho...

The discrepancy in life expectancy for Baltimore city residents is eye-opening.  Some Baltimore communities may expect to live to 66 (the same as Pakistan) years while other communities may expect much higher life expectancy.   L...

We will be reviewing a real-world situation impacting the State of Delaware's self funded insurance plan and their health plan members.   Costs are rising due to some extent by Ozempic and as expected premium cost increases are under consi...

As downward cost pressures continue to stress and overburdened healthcare delivery system, health insurance plans continue to increase cost sharing to health plan members.   These cost sharing increases are placing insurance out of reach f...

Join me as we explore new and innovative approaches to control healthcare costs and improve patient outcomes.

Learn about the newest cutting edge ways to control healthcare costs and improve patient outcomes through targeting new medical devices and pharmaceuticals.